[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021

 US$ 3,500.00

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Indoleamine 2,3 Dioxygen...

March 2021 133 pages

Insulin Resistance (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,000.00

Insulin Resistance (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insulin Resistance - Drugs in Developme...

March 2021 56 pages

Interleukin 1 (IL1) - Drugs in Development, 2021

 US$ 3,500.00

Interleukin 1 (IL1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Interleukin 1 - Drugs in Development, 2021'; Interleukin 1 (IL1) pipeline Target constitutes close...

March 2021 162 pages

Iron Deficiency Anemia (Hematology) - Drugs in Development, 2021

 US$ 2,000.00

Iron Deficiency Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia - Drugs in Developme...

March 2021 102 pages

Ischemia Reperfusion Injury (Cardiovascular) - Drugs in Development, 2021

 US$ 2,500.00

Ischemia Reperfusion Injury (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury - Drug...

March 2021 202 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021

 US$ 3,500.00

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 SUMMARY Islet Amyloid Polypeptide (Amylin or Diabetes Associated Pe...

March 2021 63 pages

Left Ventricular Dysfunction (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Left Ventricular Dysfunction (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Dr...

March 2021 50 pages

Lyme Disease (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Lyme Disease (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lyme Disease - Drugs in Development, 2021, pr...

March 2021 67 pages

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021

 US$ 3,500.00

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Lysosomal Alpha Glucosidase - Dru...

March 2021 87 pages

Male Hypogonadism (Women's and Male Health) - Drugs in Development, 2021

 US$ 2,000.00

Male Hypogonadism (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Drugs in Develo...

March 2021 104 pages

Microscopic Polyangiitis (MPA) (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Microscopic Polyangiitis (MPA) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis (MPA) - Dr...

March 2021 69 pages

Mumps (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Mumps (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Drugs in Development, 2021, provides an over...

March 2021 34 pages

Myasthenia Gravis (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Myasthenia Gravis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Drugs in Development, 2021,...

March 2021 283 pages

Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngitis - Dru...

March 2021 42 pages

Nocturia (Genitourinary Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Nocturia (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Drugs in Development, 2021, provi...

March 2021 33 pages

Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,500.00

Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatt...

March 2021 436 pages

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,500.00

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Alcoholic Steatohep...

March 2021 1254 pages

Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obsessive-Compulsive Dis...

March 2021 72 pages

Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Onychomycosis (Tinea Unguium) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis - Drugs in Dev...

March 2021 81 pages

Opioid-Induced Constipation (OIC) (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Opioid-Induced Constipation (OIC) (Other Diseases) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation...

March 2021 50 pages

Otitis Media (Ear Nose Throat Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Otitis Media (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Otitis Media - Drugs in Development, 2...

March 2021 92 pages

Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Drugs in Development, 2021

 US$ 3,500.00

Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Drugs in Development, 2021 SUMMARY Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Phenylalanine 4...

March 2021 65 pages

Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021

 US$ 2,000.00

Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria - Drugs in Developme...

March 2021 91 pages

Plague (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Plague (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plague - Drugs in Development, 2021, provides an ov...

March 2021 51 pages

Post-Operative Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Post-Operative Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Drugs in Dev...

March 2021 314 pages

Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic S...

March 2021 254 pages

Prader-Willi Syndrome (PWS) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Prader-Willi Syndrome (PWS) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prader-Willi Syndrome - Drugs i...

March 2021 113 pages

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prim...

March 2021 156 pages

Primary Sclerosing Cholangitis (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Primary Sclerosing Cholangitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangiti...

March 2021 184 pages

Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Drugs in Development, 2021

 US$ 3,500.00

Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Drugs in Development, 2021 SUMMARY Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Protein kinase C theta (PKC-?...

March 2021 32 pages

Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Reflux...

March 2021 115 pages

Restless Legs Syndrome (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Restless Legs Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Drugs...

March 2021 57 pages

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

 US$ 2,500.00

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Drugs in Development,...

March 2021 1227 pages

Sarcopenia (Musculoskeletal) - Drugs in Development, 2021

 US$ 2,000.00

Sarcopenia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Drugs in Development, 2021, provides...

March 2021 102 pages

Secondary Hyperparathyroidism (Hormonal Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Secondary Hyperparathyroidism (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidis...

March 2021 63 pages

Sedation (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Sedation (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sedation - Drugs in Development, 2021, provid...

March 2021 64 pages

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,500.00

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) pip...

March 2021 35 pages

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,500.00

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Proto-o...

March 2021 56 pages

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,500.00

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'SerineThreonine Protein K...

March 2021 46 pages

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,500.00

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) pipelin...

March 2021 46 pages

Smallpox (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Smallpox (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides a...

March 2021 88 pages

Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes I...

March 2021 34 pages

Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021

 US$ 2,500.00

Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis - Drugs in Dev...

March 2021 489 pages

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Drugs in Development, 2021

 US$ 3,500.00

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Drugs in Development, 2021 SUMMARY According to the recently published report 'TGF Beta Receptor...

March 2021 36 pages

Thromboembolism (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Thromboembolism (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thromboembolism - Drugs in Development, 2021,...

March 2021 165 pages

Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021

 US$ 3,500.00

Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecule...

March 2021 91 pages

Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021

 US$ 3,500.00

Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 8 (CD288 or TLR8) - Toll-like receptor 8 is a protein encoded by the TLR8 gene. It control host immune resp...

March 2021 111 pages

Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Drugs in Develop...

March 2021 74 pages

Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021

 US$ 3,500.00

Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021 SUMMARY Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the tra...

March 2021 116 pages

Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Drugs...

March 2021 514 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1